Inventor · disambiguated record
Gregory P. Conley
Also filed as: CONLEY GREGORY P · CONLEY GREGORY PAUL
8 granted patents·4 pending applications·47 citations·filing 2014–2025
85Inventor score
Top patents by PatentIndex Score
12 records- 0195US12084515B2Compositions and methods for treatment of diabetic macular edemaTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Sep 10, 2024·4 cites·10 claims
- 0295US11046785B2Compositions and methods for treatment of diabetic macular edemaDYAX CORP·Filed 2019·Granted Jun 29, 2021·11 cites·7 claims
- 0392US10428158B2Compositions and methods for treatment of diabetic macular edemaDYAX CORP·Filed 2015·Granted Oct 1, 2019·14 cites·9 claims
- 0490US11372002B2Assays for determining plasma kallikrein system biomarkersTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Jun 28, 2022·9 cites·15 claims
- 0587US11156612B2Methods of determining levels of cleaved and/or intact kininogenTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Oct 26, 2021·6 cites·15 claims
- 0679US11390687B2Bispecific antibodies against plasma kallikrein and Factor XIITAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jul 19, 2022·3 cites·26 claims
- 0775US12442824B2Assays for determining plasma kallikrein system biomarkersTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Oct 14, 2025·0 cites·9 claims
- 0866US12240918B2Bispecific antibodies against plasma kallikrein and factor XIITAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Mar 4, 2025·0 cites·16 claims
- 0964US2022170936A1Evaluation and treatment of bradykinin-mediated disordersTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 1063US2025381255A1Anti-asgr1 polypeptides and methods of use for immune toleranceANOKION SA·Filed 2023·Application pending·0 cites
- 1147US2022153859A1Glycophorin a antigen-binding proteinsANOKION SA·Filed 2019·Application pending·0 cites
- 1244US2025263504A1Bispecific antibodies against plasma kallikrein and factor xiiTAKEDA PHARMACEUTICALS CO·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gregory P. Conley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →